Seek Labs
Seek Labs is a biotechnology company headquartered in Salt Lake City, Utah, dedicated to advancing scientific discovery and delivering universal healthcare solutions. The company specializes in next-generation point-of-care molecular diagnostics and programmable CRISPR-based therapeutics, aiming to bridge the gap between disease outbreak and intervention. Powered by its proprietary AI discovery engine, BioSeeker™, Seek Labs is building a modular, full-stack system that enables rapid response to emerging pathogens, scalable precision treatments, and accessible diagnostics. The company is committed to global health innovation, sustainability, and community engagement, and is a proud member of Utah's BioHive life sciences ecosystem. Seek Labs' mission is to empower individuals with healthcare solutions tailored to their specific needs, revolutionizing the detection and treatment of diseases for both human and animal health.
Industries
Nr. of Employees
small (1-50)
Patents
Products
AI-powered genomic discovery engine
An AI engine that identifies, ranks, and optimizes genetic targets for use in diagnostics and therapeutic design and prioritization.
Programmable CRISPR therapeutic platform
A platform for designing sequence-specific CRISPR-based therapeutics intended to ablate pathogen sequences required for replication and spread.
Equipment-free point-of-care molecular diagnostic platform
A fully integrated, instrument-free molecular test designed to deliver laboratory-grade results in decentralized and resource-limited settings without external power or instruments.
AI-powered genomic discovery engine
An AI engine that identifies, ranks, and optimizes genetic targets for use in diagnostics and therapeutic design and prioritization.
Programmable CRISPR therapeutic platform
A platform for designing sequence-specific CRISPR-based therapeutics intended to ablate pathogen sequences required for replication and spread.
Equipment-free point-of-care molecular diagnostic platform
A fully integrated, instrument-free molecular test designed to deliver laboratory-grade results in decentralized and resource-limited settings without external power or instruments.
Expertise Areas
- AI-driven genomic target discovery
- Programmable CRISPR therapeutics
- Point-of-care molecular diagnostics
- Genomic surveillance and mapping
Key Technologies
- CRISPR-based gene editing
- AI-driven bioinformatics and target ranking
- Point-of-care molecular testing platforms
- Genomic surveillance / adaptive genomic atlas
Key People
Chief Executive Officer (CEO)
Vice President of Pharmaceutical Research
Vice President of Research
Vice President of Veterinary Pharmaceutical Development
Chief Strategy Officer
Co-Founder, Advisor (Former Chief Business Development Officer)
Chief Executive Officer (CEO)
Vice President of Pharmaceutical Research
Vice President of Research
Vice President of Veterinary Pharmaceutical Development
Chief Strategy Officer
Co-Founder, Advisor (Former Chief Business Development Officer)
News & Updates
Seek Labs was named an Emerging finalist in the Healthcare and Life Sciences category for the 2024 Utah Business Innovation Awards, recognizing the innovation of SeekIt™ diagnostics.
Dr. Alison O’Mahony, VP of Pharmaceutical Research, was honored for her leadership and commitment to innovative CRISPR-based therapeutics.
Dr. Anindita Roy, VP of Research, received the 2025 Women Tech Council Rising Star Award for her contributions to diagnostics innovation.
Seek Labs was chosen to participate in the ARPA-H Investor Catalyst Hub Spoke Network and RRPV, supporting rapid response to health threats.
CEO Jared Bauer discusses the personal motivation behind Seek Labs and the development of BioSeeker, PTAP, and SeekIt as a modular system to accelerate disease response.
An exploration of the resurgence of measles, the limitations of relying solely on vaccines, and how BioSeeker and PTAP enable proactive global preparedness.
Seek Labs was named an Emerging finalist in the Healthcare and Life Sciences category for the 2024 Utah Business Innovation Awards, recognizing the innovation of SeekIt™ diagnostics.
Dr. Alison O’Mahony, VP of Pharmaceutical Research, was honored for her leadership and commitment to innovative CRISPR-based therapeutics.
Dr. Anindita Roy, VP of Research, received the 2025 Women Tech Council Rising Star Award for her contributions to diagnostics innovation.
Seek Labs was chosen to participate in the ARPA-H Investor Catalyst Hub Spoke Network and RRPV, supporting rapid response to health threats.
CEO Jared Bauer discusses the personal motivation behind Seek Labs and the development of BioSeeker, PTAP, and SeekIt as a modular system to accelerate disease response.
An exploration of the resurgence of measles, the limitations of relying solely on vaccines, and how BioSeeker and PTAP enable proactive global preparedness.